First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of 11:44am ET
 -3.12 / -2.15%
Today’s Change
Today|||52-Week Range
FBT Regular Dividend: FBT began trading ex-dividend on 06/21/18. A $0.00 dividend will be paid to shareholders of record as of 06/22/18.

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month+5.71% 3 years+4.35%
3 months+7.05% 5 years+21.31%
1 year+23.24% Since inception+18.08%
Data through 06/23/2018

Quote Details

Previous close$145.28
Open day’s range141.93 – 144.56
Net asset value (NAV)145.18 (06/22/2018)
Daily volume19,825
Average volume (3 months)63,211
Data as of 11:44am ET, 06/25/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+21.31%+14.29%
Expense Gross exp ratio0.56%1.29%
Risk 5 year sharpe ratio0.840.90
Net assets$1.5B$3.0B
Average market cap$11.6B$28.5B
Average P/E--25.2
Dividend / Share--0.30%


FHLC Fidelity® MSCI Health Care Index ETF
XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
RARE Ultragenyx Pharmaceutical Inc4.32%
SGEN Seattle Genetics Inc3.90%
NBIX Neurocrine Biosciences Inc3.88%
FGEN FibroGen Inc3.72%
BIIB Biogen3.58%
ILMN Illumina Inc3.56%
QGEN Qiagen NV3.54%
BMRN Biomarin Pharmaceutical Inc3.52%
AGIO Agios Pharmaceuticals Inc3.46%
ALXN Alexion Pharmaceuticals Inc3.45%